Chestal Childrens Cough And Cold

Solanum Dulcamara Top, Ferrum Phosphoricum, Goldenseal, Potassium Dichromate, Strychnos Nux-vomica Seed

Laboratoires Boiron
Human Otc Drug
NDC 0220-9068

Chestal Childrens Cough And Cold also known as Solanum Dulcamara Top, Ferrum Phosphoricum, Goldenseal, Potassium Dichromate, Strychnos Nux-vomica Seed is a human otc drug labeled by 'Laboratoires Boiron'. National Drug Code (NDC) number for Chestal Childrens Cough And Cold is 0220-9068. This drug is available in dosage form of Syrup. The names of the active, medicinal ingredients in Chestal Childrens Cough And Cold drug includes Ferrum Phosphoricum - 9 [hp_C]/mL Goldenseal - 9 [hp_C]/mL Potassium Dichromate - 9 [hp_C]/mL Solanum Dulcamara Top - 5 [hp_C]/mL Strychnos Nux-vomica Seed - 9 [hp_C]/mL . The currest status of Chestal Childrens Cough And Cold drug is Active.

Drug Information:

Drug NDC:	0220-9068
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Chestal Childrens Cough And Cold
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Solanum Dulcamara Top, Ferrum Phosphoricum, Goldenseal, Potassium Dichromate, Strychnos Nux-vomica Seed
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Laboratoires Boiron
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Syrup
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	FERRUM PHOSPHORICUM - 9 [hp_C]/mL GOLDENSEAL - 9 [hp_C]/mL POTASSIUM DICHROMATE - 9 [hp_C]/mL SOLANUM DULCAMARA TOP - 5 [hp_C]/mL STRYCHNOS NUX-VOMICA SEED - 9 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Jun, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	09 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Laboratoires Boiron
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000185375 N0000175629 N0000184306 N0000185001 M0000728 M0016962 M0516536
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	91GQH8I5F7 ZW3Z11D0JV T4423S18FM KPS1B1162N 269XH13919
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Non-Standardized Plant Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE] Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Allergens [CS] Plant Proteins [CS] Seed Storage Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Allergens [CS] Cell-mediated Immunity [PE] Increased Histamine Release [PE] Increased IgG Production [PE] Non-Standardized Plant Allergenic Extract [EPC] Plant Proteins [CS] Seed Storage Proteins [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
0220-9068-28	1 BOTTLE in 1 PACKAGE (0220-9068-28) / 200 mL in 1 BOTTLE	01 Jun, 2013	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Chestal Cough And Cold

Solanum Dulcamara Top & more..

Syrup
Laboratoires Boiron
NDC: 0220-9067

Chestal Childrens Cough And Cold

Solanum Dulcamara Top & more..

Syrup
Laboratoires Boiron
NDC: 0220-9068

Purpose:

Dulcamara 5c hpus ... relieves cold and coughs worsened by exposure to damp cold* ferrum phosphoricum 9c hpus ... relieves colds with gradual onset, minor sore throat, and dry, fitful cough* hydrastis canadensis 9c hpus ... relieves colds and coughs associated with runny nose* kali bichromicum 9c hpus ... relieves nasal discharge* nux vomica 9c hpus (0.13mg) ... relieves sneezing fits*

Product Elements:

Chestal childrens cough and cold solanum dulcamara top, ferrum phosphoricum, goldenseal, potassium dichromate, strychnos nux-vomica seed alcohol citric acid monohydrate water sodium benzoate sucrose solanum dulcamara top solanum dulcamara top ferrum phosphoricum ferrosoferric phosphate goldenseal goldenseal potassium dichromate dichromate ion strychnos nux-vomica seed strychnos nux-vomica seed

Indications and Usage:

Temporarily relieves symptoms of the common cold such as: nasal and chest congestion, fitful cough, sneezing, minor sore throat, runny or stuff nose*

Warnings:

Ask a doctor before use if your child has severe sore throat that is accompanied or followed by fever, headache, rash, nausea, or vomiting persistent or chronic cough such as occurs with asthma cough and occurs with too much phlegm (mucus). stop use and ask a doctor if sore throat persists for more than 2 days cough lasts for more than 7 days, comes back, or is accompanied by fever, rash or a persistent headache. these could be signs of a serious condition. keep out of reach of children. in case of accidental overdose, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions children 6 to 11 years of age take 5 ml Ç as needed, up to 6 times per day children 3 to 5 years of age take 5 mlÇ as needed, up to 3 times per day children under 3 years of age not recommended Ç use only with dosing cup provided. do not use dosing cup with other products.

Stop Use:

Stop use and ask a doctor if sore throat persists for more than 2 days cough lasts for more than 7 days, comes back, or is accompanied by fever, rash or a persistent headache. these could be signs of a serious condition.

Package Label Principal Display Panel:

Label label box

Further Questions:

Questions or comments? 1-800-boiron-1 (1-800-264-7661), boironusa.com info@boiron.com distributed by boiron, inc. newtown square, pa 19073

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.